{"id":76806,"date":"2024-09-23T15:02:09","date_gmt":"2024-09-23T19:02:09","guid":{"rendered":"https:\/\/todaysveterinarybusiness.com\/?p=76806"},"modified":"2024-09-23T15:02:09","modified_gmt":"2024-09-23T19:02:09","slug":"elancos-zenrelia-092324","status":"publish","type":"post","link":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/","title":{"rendered":"Elanco\u2019s Zenrelia Receives FDA Approval"},"content":{"rendered":"<p>The Food and Drug Administration has approved Zenrelia, a once-daily oral JAK inhibitor for managing pruritus associated with canine allergic and <a href=\"https:\/\/todaysveterinarybusiness.com\/keep-skin-in-the-gam\/\">atopic dermatitis<\/a>.<\/p>\n<p>According to the manufacturer, Elanco Animal Health, Zenrelia (ilunocitinib tablets) blocks the pathways involved in allergic pruritus to break the itch-scratch cycle and minimize the risk of rebound itch.<\/p>\n<p>\u201cZenrelia\u2019s once-daily dosing is more convenient and will be affordable for pet owners with the launch list price about 20% less for nearly all dogs compared to the current JAK inhibitor,\u201d said Bobby Modi, Elanco\u2019s executive vice president of U.S. Pet Health and Global Digital Transformation.<\/p>\n<p>A randomized, double-blinded noninferiority study compared Zenrelia and Apoquel, the competing JAK inhibitor from Zoetis. According to Elanco, the findings included:<\/p>\n<ul>\n<li>Zenrelia consistently provided greater relief from <a href=\"https:\/\/todaysveterinarypractice.com\/clinical_topics\/dermatology\/\">itching and skin lesions<\/a> with once-daily dosing from the start of treatment. In contrast, dogs treated with Apoquel showed rebound itching when the dosing was reduced to once daily after Day 14.<\/li>\n<li>Owners and veterinarians noticed a different treatment response, consistently rating Zenrelia higher than Apoquel for overall effectiveness from Day 28 to Day 112.<\/li>\n<li>The adverse event profiles were comparable among the Zenrelia and Apoquel groups.<\/li>\n<\/ul>\n<p>\u201cPet owners will appreciate greater savings in the first 14 days for Zenrelia, given its single versus twice-daily dosing,\u201d Modi said.<\/p>\n<p>According to Elanco, multiple toxicity and clinical safety studies demonstrated Zenrelia\u2019s safety.<\/p>\n<p>\u201cWe recognize that veterinarians need clinically relevant data to guide treatment choices and plan to pursue additional studies to evaluate vaccine response in Zenrelia-treated dogs,\u201d Modi said.<\/p>\n<p>Veterinarians may prescribe the drug to dogs at least 12 months old.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The prescription canine medication is formulated to control pruritus associated with allergic and atopic dermatitis.<\/p>\n","protected":false},"author":23,"featured_media":76807,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"iawp_total_views":0,"footnotes":""},"categories":[90],"tags":[],"class_list":["post-76806","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-online","column-news","clinical_topics-veterinary-products"],"acf":{"hide_sidebar":false,"hide_sidebar_ad":false,"hide_all_ads":false},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.7 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Elanco\u2019s Zenrelia Receives FDA Approval | Today&#039;s Veterinary Business<\/title>\n<meta name=\"description\" content=\"Zenrelia is a once-daily oral JAK inhibitor for managing pruritus associated with canine allergic and atopic dermatitis.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elanco\u2019s Zenrelia Receives FDA Approval\" \/>\n<meta property=\"og:description\" content=\"Zenrelia is a once-daily oral JAK inhibitor for managing pruritus associated with canine allergic and atopic dermatitis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/\" \/>\n<meta property=\"og:site_name\" content=\"Today&#039;s Veterinary Business\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/todaysveterinarybusiness\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-23T19:02:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2024\/09\/Zenrelia-US.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"544\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ken Niedziela\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@tvbpublication\" \/>\n<meta name=\"twitter:site\" content=\"@tvbpublication\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ken Niedziela\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/\"},\"author\":{\"name\":\"Ken Niedziela\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/person\\\/e7a7f164d6002302a37a738b8ef561d7\"},\"headline\":\"Elanco\u2019s Zenrelia Receives FDA Approval\",\"datePublished\":\"2024-09-23T19:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/\"},\"wordCount\":268,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/09\\\/Zenrelia-US.jpg\",\"articleSection\":[\"Online\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/\",\"name\":\"Elanco\u2019s Zenrelia Receives FDA Approval | Today&#039;s Veterinary Business\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/09\\\/Zenrelia-US.jpg\",\"datePublished\":\"2024-09-23T19:02:09+00:00\",\"description\":\"Zenrelia is a once-daily oral JAK inhibitor for managing pruritus associated with canine allergic and atopic dermatitis.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#primaryimage\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/09\\\/Zenrelia-US.jpg\",\"contentUrl\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/09\\\/Zenrelia-US.jpg\",\"width\":1024,\"height\":544,\"caption\":\"Zenrelia is available in doses of 4.8, 6.4, 8.5 and 15 milligrams.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elancos-zenrelia-092324\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elanco\u2019s Zenrelia Receives FDA Approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#website\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/\",\"name\":\"Today&#039;s Veterinary Business\",\"description\":\"Veterinary Business Magazine\",\"publisher\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#organization\",\"name\":\"Today's Veterinary Business\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/02\\\/tvb-logo.png\",\"contentUrl\":\"https:\\\/\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/02\\\/tvb-logo.png\",\"width\":258,\"height\":71,\"caption\":\"Today's Veterinary Business\"},\"image\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/todaysveterinarybusiness\",\"https:\\\/\\\/x.com\\\/tvbpublication\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/todaysveterinarybusiness\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/person\\\/e7a7f164d6002302a37a738b8ef561d7\",\"name\":\"Ken Niedziela\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e7640fb1b956282b0becceef26c9a2d6eae05d811b405c45feb1892aba036cf?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e7640fb1b956282b0becceef26c9a2d6eae05d811b405c45feb1892aba036cf?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e7640fb1b956282b0becceef26c9a2d6eae05d811b405c45feb1892aba036cf?s=96&d=mm&r=g\",\"caption\":\"Ken Niedziela\"},\"sameAs\":[\"http:\\\/\\\/navc.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Elanco\u2019s Zenrelia Receives FDA Approval | Today&#039;s Veterinary Business","description":"Zenrelia is a once-daily oral JAK inhibitor for managing pruritus associated with canine allergic and atopic dermatitis.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Elanco\u2019s Zenrelia Receives FDA Approval","og_description":"Zenrelia is a once-daily oral JAK inhibitor for managing pruritus associated with canine allergic and atopic dermatitis.","og_url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/","og_site_name":"Today&#039;s Veterinary Business","article_publisher":"https:\/\/www.facebook.com\/todaysveterinarybusiness","article_published_time":"2024-09-23T19:02:09+00:00","og_image":[{"width":1024,"height":544,"url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2024\/09\/Zenrelia-US.jpg","type":"image\/jpeg"}],"author":"Ken Niedziela","twitter_card":"summary_large_image","twitter_creator":"@tvbpublication","twitter_site":"@tvbpublication","twitter_misc":{"Written by":"Ken Niedziela","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#article","isPartOf":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/"},"author":{"name":"Ken Niedziela","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/person\/e7a7f164d6002302a37a738b8ef561d7"},"headline":"Elanco\u2019s Zenrelia Receives FDA Approval","datePublished":"2024-09-23T19:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/"},"wordCount":268,"commentCount":0,"publisher":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#organization"},"image":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#primaryimage"},"thumbnailUrl":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2024\/09\/Zenrelia-US.jpg","articleSection":["Online"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/","name":"Elanco\u2019s Zenrelia Receives FDA Approval | Today&#039;s Veterinary Business","isPartOf":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#primaryimage"},"image":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#primaryimage"},"thumbnailUrl":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2024\/09\/Zenrelia-US.jpg","datePublished":"2024-09-23T19:02:09+00:00","description":"Zenrelia is a once-daily oral JAK inhibitor for managing pruritus associated with canine allergic and atopic dermatitis.","breadcrumb":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#primaryimage","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2024\/09\/Zenrelia-US.jpg","contentUrl":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2024\/09\/Zenrelia-US.jpg","width":1024,"height":544,"caption":"Zenrelia is available in doses of 4.8, 6.4, 8.5 and 15 milligrams."},{"@type":"BreadcrumbList","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elancos-zenrelia-092324\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/"},{"@type":"ListItem","position":2,"name":"Elanco\u2019s Zenrelia Receives FDA Approval"}]},{"@type":"WebSite","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#website","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/","name":"Today&#039;s Veterinary Business","description":"Veterinary Business Magazine","publisher":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#organization","name":"Today's Veterinary Business","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/logo\/image\/","url":"https:\/\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2022\/02\/tvb-logo.png","contentUrl":"https:\/\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2022\/02\/tvb-logo.png","width":258,"height":71,"caption":"Today's Veterinary Business"},"image":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/todaysveterinarybusiness","https:\/\/x.com\/tvbpublication","https:\/\/www.linkedin.com\/company\/todaysveterinarybusiness"]},{"@type":"Person","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/person\/e7a7f164d6002302a37a738b8ef561d7","name":"Ken Niedziela","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3e7640fb1b956282b0becceef26c9a2d6eae05d811b405c45feb1892aba036cf?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e7640fb1b956282b0becceef26c9a2d6eae05d811b405c45feb1892aba036cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e7640fb1b956282b0becceef26c9a2d6eae05d811b405c45feb1892aba036cf?s=96&d=mm&r=g","caption":"Ken Niedziela"},"sameAs":["http:\/\/navc.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts\/76806","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/comments?post=76806"}],"version-history":[{"count":1,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts\/76806\/revisions"}],"predecessor-version":[{"id":76808,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts\/76806\/revisions\/76808"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/media\/76807"}],"wp:attachment":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/media?parent=76806"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/categories?post=76806"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/tags?post=76806"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}